# US 2026/0216078 A1 · Water-soluble capsaicin metal complexes and method of preparation thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0216078 A1
- Document ID: US20260216078A1
- Status: Published application
- Kind: A1
- Application number: 19/396,267
- Filed: 2025-11-20
- Published: 2026-07-30
- Earliest claimed: 2024-11-20
- Assignees: ThermoLife International, LLC
- Applicants: ThermoLife International, LLC
- Inventors: Ronald KRAMER; Alexandros NIKOLAIDIS
- Web page: https://patentgrep.com/patent/US20260216078A1

## CPC

- A61K 9/14: Particulate form, e.g. powders, {Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles (microspheres A61K9/16; microcapsules A61K9/50; nanocapsules, nanoparticles of the matrix type A61K9/51)}
- C07C 233/20: having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
- A23L 33/10: using additives (addition of substantially indigestible substances A23L33/21)
- A23L 33/16: Inorganic salts, minerals or trace elements
- A61K 9/0053: {Mouth and digestive tract, i.e. intraoral and peroral administration}
- A61K 31/166: having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)

## Abstract

A metal-capsaicinoid complex that renders the capsaicinoid water-soluble is disclosed along with related compositions. Methods of producing the metal-capsaicinoid complex are also disclosed.

## Claims

### Claim 1

A solid composition of matter comprising:
5-95% by weight of a capsaicinoid; and
5-95% by weight of a metal.

### Claim 2 (depends on 1)

The composition of claim 1 where the composition also comprises 5-95% of an alkoxide.

### Claim 3 (depends on 1)

The composition of claim 1, wherein the capsaicinoid is capsaicin.

### Claim 4 (depends on 1)

The composition of claim 1, wherein the metal is selected from the group consisting of: lithium, sodium, and potassium.

### Claim 5 (depends on 1)

The composition of claim 1, wherein the capsaicinoid in the composition is not aggregated together.

### Claim 6 (depends on 1)

The composition of claim 1, wherein at least a portion of the capsaicinoid is complexed to the metal.

### Claim 7 (depends on 1)

The composition of claim 1, wherein the composition is soluble in water at a solubility of at least 0.1 g/100 ml water.

### Claim 8 (depends on 1)

A method of preparing the compositions of any one of claim 1, said method comprising:
dissolving the metal in a polar solvent to produce a solution comprising the dissolved metal;
dissolving the capsaicinoid in the solution comprising the dissolved metal to produce a complexing solution;
stirring the complexing solution until a homogenous solution is formed; and
evaporating the polar solvent in the homogenous solution, thereby producing a dried product comprising metal-capsaicinoid complex.

### Claim 9 (depends on 8)

The method of claim 8, where the capsaicinoid and the metal are in a molar ratio of between 1:1 and 1:100 (capsaicinoid: metal).

### Claim 10 (depends on 8)

The method of claim 8, where the polar solvent is ethanol.

### Claim 11 (depends on 8)

The method of claim 8, where the metal is potassium and the capsaicinoid is capsaicin.

### Claim 12 (depends on 8)

A method of treating a capsaicin-treatable condition by administering to a subject a pharmaceutically effective amount of metal-capsaicinoid complex produced according to the method of claim 8.

### Claim 13 (depends on 12)

The method of claim 12, where the capsaicin-treatable condition is one of: acute pain, chronic pain, back pain, diabetic neuropathy, postherpetic neuralgia, migraine, cluster headache, allergic rhinitis, non-allergic rhinitis, osteoarthritis, postoperative nausea and vomiting, burning mouth syndrome, cardiovascular disease, hyperlipidemia, dry skin, dyslipidemia, dyspepsia, fibromyalgia, gastroesophageal reflux disease, HIV related peripheral neuropathy, hypertension, intrametatarsal neuroma, irritable bowel syndrome, laryngitis, motion sickness, myofascial face syndrome, neck pain, neuropathic pain, obesity, peptic ulcers, prurigo nodularis, sinonasal polyposis, and swallowing dysfunction.

### Claim 14 (depends on 8)

A method of producing a capsaicin-caused health improvement in a subject comprising administering to the subject a pharmaceutically effective amount of a metal-capsaicinoid complex produced according to the method of claim 8.

### Claim 15 (depends on 13)

The method of claim 13, where the capsaicin-caused health improvement is one of: increased athletic performance, increased fat loss, increased caloric expenditure, reduction of body fat, decrease in blood sugar, increase of insulin sensitivity, increase of endurance, increase of absorption of creatine, and increase of muscular strength.

### Claim 16 (depends on 12)

The method of claim 12, where the subject is orally administered the metal-capsaicinoid complex produced.

### Claim 17 (depends on 16)

The method of claim 16, wherein the pharmaceutically effective amount of the metal-capsaicinoid complex is between 1-1000 mg.

### Claim 18

A supplemental formulation comprising:
a metal-capsaicinoid complex; and
a second supplement ingredient and/or a pharmaceutically acceptable additive.

### Claim 19 (depends on 18)

The supplemental formulation of claim 18 wherein the metal-capsaicinoid comprises capsaicin.

### Claim 20 (depends on 18)

The supplemental formulation of claim 18, wherein the metal-capsaicinoid comprises a metal selected from the group consisting of: lithium, sodium, and potassium.
